Get the content you want anytime you want.

Society of Infectious Diseases Pharmacists

Society of Infectious Diseases Pharmacists
Founded in 1990, the Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and allied healthcare professionals dedicated to promoting the appropriate use of antimicrobial agents.

Latest Partner Content

COVID-19 Treatment: Updates March 19-24, 2020
Erin K. McCreary, PharmD, BCPS, BCIDP; and Jason M. Pogue, PharmD, BCPS, BCIDP, provide an update of published literature on experimental treatments for COVID-19 from the past week.
Oseltamivir on the Move, but Where Should It Go?
Just as influenza season started ramping up in the Northern Hemisphere, news hit the wire that Sanofi had secured over-the-counter rights for oseltamivir (Tamiflu).
Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice. 
Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options. 
Consider the MIC: Treating Respiratory Infections Caused by <i>Pseudomonas aeruginosa</i> With Ceftolozane/Tazobactam
When using ceftolozane/ tazobactam to treat patients with P aeruginosa respiratory tract infections, the use of extended or continuous antibiotic infusion and/or combination therapy with other active antibiotic agents should be considered, particularly if targeting higher MIC values.
The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
Preliminary Negative Cultures for the De-Escalation of MRSA Therapy
This article evaluates the point in microbiological workup at which results of respiratory secretion and blood cultures could be interpreted as excluding MRSA and, thus, no longer warrant the empirical vancomycin therapy.
Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis
A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?